STOCK TITAN
  1. Home
  2. Sec-filings
  3. DNA
  4. [144] Ginkgo Bioworks Holdings, Inc. SEC Filing

[144] Ginkgo Bioworks Holdings, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock DNA logo
Ginkgo Bioworks Holdings Inc

NYSE:DNA

DNA Rankings

#4571 Ranked by Market Cap
N/A Ranked by Dividends

DNA Latest News

Jul 17, 2025
Ginkgo Bioworks Launches ADME Profiling Service Using Lab Automation, Offering a US-based Operation That Will Match or Beat Pricing Quotes from Chinese or Other International Vendors
May 21, 2025
Ginkgo Bioworks Announces Appointment of Steven Coen as Chief Financial Officer
May 8, 2025
Twist Bioscience and Ginkgo Bioworks Revise Collaboration
May 6, 2025
Ginkgo Bioworks Reports First Quarter 2025 Financial Results
Apr 30, 2025
Phytolon and Ginkgo Bioworks Boost Natural Food Colors by Hitting Full-Project Milestone, Nearly Tripling the Manufacturing Efficiency of Phytolon's Innovative Colors

DNA Latest SEC Filings

Jul 9, 2025
[144] Ginkgo Bioworks Holdings, Inc. SEC Filing
Jun 23, 2025
[144] Ginkgo Bioworks Holdings, Inc. SEC Filing
Jun 20, 2025
[144] Ginkgo Bioworks Holdings, Inc. SEC Filing

DNA Stock Data

647.95M
54.73M
6.6%
79.85%
15.62%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
BOSTON